Stockscreener 앱 받기
0.4831
3.90%
-0.0196
전일 마감가:
$0.5027
열려 있는:
$0.514
하루 거래량:
65,834
Relative Volume:
0.84
시가총액:
$12.71M
수익:
-
순이익/손실:
$-60.11M
주가수익비율:
-0.1111
EPS:
-4.347
순현금흐름:
$-12.04M
1주 성능:
-32.44%
1개월 성능:
-31.97%
6개월 성능:
-55.27%
1년 성능:
-43.83%
1일 변동 폭
$0.483
$0.5179
1주일 범위
$0.483
$0.7459
52주 변동 폭
$0.483
$1.45
AEON Biopharma Inc. Stock (AEON) Company Profile
명칭
AEON Biopharma Inc.
전화
(949) 354-6499
주소
5 Park Plaza, Suite 1750, Irvine
Compare AEON vs VRTX, REGN, ARGX, ALNY, RVMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
AEON
AEON Biopharma Inc.
|
0.4831 | 12.71M | 0 | -60.11M | -12.04M | -4.347 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
AEON Biopharma Inc. Stock (AEON) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2023-08-18 | 개시 | H.C. Wainwright | Buy |
AEON Biopharma Inc. 주식(AEON)의 최신 뉴스
AEON Biopharma (NASDAQ: AEON) revises S-1 filing fee table for milestone warrants - Stock Titan
AEON Biopharma Offering 17.5M Shrs or Pre-Funded Warrants Along With Two-Year and Five-Year Milestone Warrants - Moomoo
Form S-1 Aeon Biopharma Inc For: 8 July By Investing.com - Investing.com Nigeria
AEON Biopharma (AEON) files S-1 for $11M stock sale plus milestone warrants - Stock Titan
AEON Q4 2025 Earnings: Wider Loss Misses Estimates Amid Pre-Revenue StageProfit Inflection Point - dars.gov.et
AEONAEON Biopharma Inc Latest SEC Filings - Finviz
Price to book forward of AEON Biopharma, Inc. – AMEX:AEON - TradingView
Price to sales forward of AEON Biopharma, Inc. – AMEX:AEON - TradingView
Enterprise value to revenue forward of AEON Biopharma, Inc. – AMEX:AEON - TradingView
AEON Biopharma, Inc. Class A Actuals & Estimates (AMEX:AEON) - TradingView
AEON Forecast — Price Target — Prediction for 2027 - TradingView
Form 4 Aeon Biopharma Inc For: 22 June By Investing.com - Investing.com Nigeria
[Form 4] AEON Biopharma, Inc. Insider Trading Activity - Stock Titan
AEON Biopharma (AEON) grants 222,684 RSUs to director Palmisano - Stock Titan
Director at AEON Biopharma (AEON) granted 222,684 RSUs - Stock Titan
AEON Biopharma (AEON) director awarded 222,684 RSUs in equity grant - Stock Titan
Director Carter granted 222,684 RSUs at AEON Biopharma (AEON) - Stock Titan
Aeon Biopharma Inc (AEON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
AEON BIOPHARMA INC (AEON) Stock Chart - ChartMill
AEON Biopharma shareholders approve directors and auditor slate - TipRanks
Aeon Biopharma Inc (AEON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Aeon Biopharma Inc (AEON) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Aeon Biopharma Inc (AEON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AEON Biopharma, Inc. Elects Each of Marc Forth and Seongsoo Park as Class III Directors of the Company's Board of Directors - marketscreener.com
AEON Biopharma (NYSE: AEON) investors back Class III board slate and KPMG - Stock Titan
Aeon Biopharma Inc (AEON) Institutional Confidence - TradingKey
Aeon Biopharma Inc (AEON) Valuation: PE, PB & Fair Value Analysis - TradingKey
Aeon Biopharma Inc (AEON) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Aeon Biopharma Inc (AEON) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Aeon Biopharma Inc (AEON) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
AEON Biopharma (AEON) Slides 7% as Selling Pressure Intensifies Near $0.67Wave Extension - newsline.com
AEON Biopharma (AEON) Holds Steady at $0.71 as Stock Consolidates Between Key Support and ResistanceSeasonality Effect - newsline.com
AEON Q4 2025 Earnings: Significant EPS Miss as Pre-Revenue Biotech Faces ChallengesRetail Earnings Report - newsline.com
Number of shareholders of AEON Biopharma, Inc. – AMEX:AEON - TradingView
AEON Biopharma Presents New Data Supporting Biosimilarity of ABP-450 to BOTOX at AHS 2026 Annual Meeting - Moomoo
AEON Biopharma to Present Data Demonstrating Structural and Functional Comparability of ABP-450 to BOTOX® at the 68th Annual Scientific Meeting of the American Headache Society - The Manila Times
Botox biosimilar ABP-450 shows similar structure and activity - Stock Titan
AEON Biopharma Presents New Data Supporting Biosimilarity of ABP-450 to BOTOX® at AHS 2026 Annual Meeting - Quiver Quantitative
AEON Technical Analysis | Trend, Signals & Chart Patterns | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill
AEON Biopharma (AEON) Surges 5.6% as Bulls Test Key Resistance at $0.80Factor ETF Flow - newsline.com
AEON Biopharma Edges Higher: Stock Rises 2.75% as it Tests Key ResistanceHigh Conviction Picks - The Legal Advocate
AEON Q4 2025 Earnings: Deep EPS Miss Amid Pre-Revenue StageEPS Miss Report - The Legal Advocate
AEON Biopharma Q4 2025 Earnings: Major EPS Miss and No Revenue Weigh on Investor SentimentEarnings Expansion Phase - Newser
AEON Biopharma Inc. (AEON) Q4 2025 Earnings: Significant EPS Miss and Stock Decline Amid Development ChallengesHigh Growth Earnings - Newser
AEON Biopharma Dips 2.74% as Stock Nears Critical Support at $0.76Watchlist Stock Ideas - Newser
12 Health Care Stocks Moving In Monday's Intraday Session - Sahm
AEON Stock Price, Quote & Chart | AEON BIOPHARMA INC (NYSEARCA:AEON) - ChartMill
AEON SEC FilingsAeon Biopharma 10-K, 10-Q, 8-K Forms - Stock Titan
AEON Biopharma Inc. (AEON) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.64%
자본화:
|
볼륨(24시간):